What is Proton Intelligence?
Proton Intelligence is a medical technology innovator dedicated to transforming the management of hyperkalemia. The company is developing the first real-time, on-demand potassium monitoring wearable device, specifically designed to assist clinicians in the precise treatment of patients at risk of high potassium levels. By targeting the millions of Americans affected by chronic kidney disease and heart failure, the company addresses a significant unmet need in the healthcare landscape. Their solution provides a critical bridge between intermittent laboratory testing and the need for continuous, actionable data, thereby empowering healthcare providers to make more informed, timely clinical decisions.
How much funding has Proton Intelligence raised?
Proton Intelligence has raised a total of $7M across 1 funding round:
Angel/Seed
$7M
Angel/Seed (2024): $7M with participation from Tenmile, We Venture, EXOR, SOSV, and 15th Rock Ventures
Key Investors in Proton Intelligence
Tenmile
Tenmile is an investment firm focused on improving human health by supporting innovative companies in the health sector, providing capital and expertise to translate scientific breakthroughs into scalable solutions.
SOSV
SOSV is a multi-stage venture capital investor that provides intellectual and financial capital to accelerate founders big ideas.
15th Rock Ventures
15th Rock is a venture capital firm specializing in the enhancement of human capabilities through technology, with a focus on supporting startups that innovate in robotics and AI.
What's next for Proton Intelligence?
With the support of its latest capital round, Proton Intelligence is poised to scale its operational capabilities and advance its regulatory strategy. The company's forward-looking roadmap focuses on refining its wearable sensor technology and conducting rigorous clinical trials to demonstrate efficacy in diverse patient populations. As the firm moves deeper into the commercialization phase, it will likely prioritize strategic partnerships with healthcare systems and nephrology centers to integrate its monitoring platform into standard care protocols. This strategic expansion is expected to solidify the company's position as a leader in the burgeoning field of remote patient monitoring and chronic disease management.
See full Proton Intelligence company page
